{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:17:56Z","timestamp":1787876276847,"version":"build-2784847793"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55820-2","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T15:04:20Z","timestamp":1781363060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome near-haploidization in CDC73-wildtype parathyroid tumors"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5724-7643","authenticated-orcid":false,"given":"Maaia Margo","family":"Jentus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Snel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke M.","family":"van Haalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Crobach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Torregrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Morreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"1","key":"55820_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12022-024-09804-5","volume":"35","author":"CC Juhlin","year":"2024","unstructured":"Juhlin, C. C. Not All Parafibromin Deficiency Relates to Parathyroid Carcinoma: The Role of Morphological Assessment. Endocr. Pathol. 35 (1), 84\u201387. https:\/\/doi.org\/10.1007\/s12022-024-09804-5 (2024).","journal-title":"Endocr. Pathol."},{"issue":"4","key":"55820_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten, J. D. et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat. Genet. 32 (4), 676\u2013680. https:\/\/doi.org\/10.1038\/ng1048 (2002).","journal-title":"Nat. Genet."},{"issue":"1","key":"55820_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/pas.0000000000001017","volume":"43","author":"AJ Gill","year":"2019","unstructured":"Gill, A. J. et al. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features. Am. J. Surg. Pathol. 43 (1), 35\u201346. https:\/\/doi.org\/10.1097\/pas.0000000000001017 (2019).","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"55820_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12022-020-09656-9","volume":"32","author":"CC Juhlin","year":"2021","unstructured":"Juhlin, C. C. & Erickson, L. A. Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice. Endocr. Pathol. 32 (1), 17\u201334. https:\/\/doi.org\/10.1007\/s12022-020-09656-9 (2021).","journal-title":"Endocr. Pathol."},{"issue":"5","key":"55820_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/modpathol.2010.236","volume":"24","author":"JE Witteveen","year":"2011","unstructured":"Witteveen, J. E. et al. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Mod. Pathol. 24 (5), 688\u2013697. https:\/\/doi.org\/10.1038\/modpathol.2010.236 (2011).","journal-title":"Mod. Pathol."},{"issue":"1","key":"55820_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1210\/clinem\/dgad455","volume":"109","author":"F Cetani","year":"2023","unstructured":"Cetani, F. et al. Approach to the Patient With Parathyroid Carcinoma. J. Clin. Endocrinol. Metab. 109 (1), 256\u2013268. https:\/\/doi.org\/10.1210\/clinem\/dgad455 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"55820_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","volume":"21","author":"S Kruijff","year":"2014","unstructured":"Kruijff, S., Sidhu, S. B., Sywak, M. S., Gill, A. J. & Delbridge, L. W. Negative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas. Ann. Surg. Oncol. 21 (2), 426\u2013433. https:\/\/doi.org\/10.1245\/s10434-013-3288-8 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"55820_CR8","doi-asserted-by":"publisher","first-page":"1905585","DOI":"10.1155\/ije\/1905585","volume":"2025","author":"J Xiao","year":"2025","unstructured":"Xiao, J., Yang, S., Zheng, Q., Chen, T. & Hu, Y. The Consistency of CDC73 Mutation and Parafibromin Staining Loss in Parathyroid Neoplasm: A Systematic Review. Int. J. Endocrinol. 2025, 1905585. https:\/\/doi.org\/10.1155\/ije\/1905585 (2025).","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"55820_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1210\/js.2018-00043","volume":"3","author":"CN Clarke","year":"2019","unstructured":"Clarke, C. N. et al. Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways. J. Endocr. Soc. 3 (3), 544\u2013559. https:\/\/doi.org\/10.1210\/js.2018-00043 (2019).","journal-title":"J. Endocr. Soc."},{"issue":"6","key":"55820_CR10","doi-asserted-by":"publisher","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","volume":"2","author":"C Pandya","year":"2017","unstructured":"Pandya, C. et al. Genomic profiling reveals mutational landscape in parathyroid carcinomas. JCI Insight. 2 (6), e92061. https:\/\/doi.org\/10.1172\/jci.insight.92061 (2017).","journal-title":"JCI Insight"},{"issue":"8","key":"55820_CR11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/01.pas.0000166368.68459.99","volume":"29","author":"JL Hunt","year":"2005","unstructured":"Hunt, J. L., Carty, S. E., Yim, J. H., Murphy, J. & Barnes, L. Allelic loss in parathyroid neoplasia can help characterize malignancy. Am. J. Surg. Pathol. 29 (8), 1049\u20131055 (2005).","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"55820_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3892\/ijo.21.4.727","volume":"21","author":"S V\u00e4lim\u00e4ki","year":"2002","unstructured":"V\u00e4lim\u00e4ki, S., Forsberg, L., Farnebo, L. O. & Larsson, C. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas. Int. J. Oncol. 21 (4), 727\u2013735. https:\/\/doi.org\/10.3892\/ijo.21.4.727 (2002).","journal-title":"Int. J. Oncol."},{"issue":"4","key":"55820_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jcem-67-4-779","volume":"67","author":"KE Levin","year":"1988","unstructured":"Levin, K. E. et al. Deoxyribonucleic acid cytometry helps identify parathyroid carcinomas. J. Clin. Endocrinol. Metab. 67 (4), 779\u2013784. https:\/\/doi.org\/10.1210\/jcem-67-4-779 (1988).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"55820_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/s0165-4608(98)00049-1","volume":"106","author":"SK Agarwal","year":"1998","unstructured":"Agarwal, S. K. et al. Comparative genomic hybridization analysis of human parathyroid tumors. Cancer Genet. Cytogenet. 106 (1), 30\u201336. https:\/\/doi.org\/10.1016\/s0165-4608(98)00049-1 (1998).","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"55820_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12020-013-9903-4","volume":"44","author":"J Costa-Guda","year":"2013","unstructured":"Costa-Guda, J. et al. Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins. Endocrine 44 (2), 489\u2013495. https:\/\/doi.org\/10.1007\/s12020-013-9903-4 (2013).","journal-title":"Endocrine"},{"issue":"5","key":"55820_CR16","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1210\/jcem.83.5.4806","volume":"83","author":"N Palanisamy","year":"1998","unstructured":"Palanisamy, N. et al. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J. Clin. Endocrinol. Metab. 83 (5), 1766\u20131770. https:\/\/doi.org\/10.1210\/jcem.83.5.4806 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"55820_CR17","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1210\/jcem.84.10.6057","volume":"84","author":"F Farnebo","year":"1999","unstructured":"Farnebo, F. et al. Alternative genetic pathways in parathyroid tumorigenesis. J. Clin. Endocrinol. Metab. 84 (10), 3775\u20133780. https:\/\/doi.org\/10.1210\/jcem.84.10.6057 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"55820_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1210\/jcem.85.4.6518","volume":"85","author":"CJ Haven","year":"2000","unstructured":"Haven, C. J. et al. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J. Clin. Endocrinol. Metab. 85 (4), 1449\u20131454. https:\/\/doi.org\/10.1210\/jcem.85.4.6518 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"55820_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/s0002-9440(10)64406-9","volume":"161","author":"T Dwight","year":"2002","unstructured":"Dwight, T. et al. Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism. Am. J. Pathol. 161 (4), 1299\u20131306. https:\/\/doi.org\/10.1016\/s0002-9440(10)64406-9 (2002).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"55820_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/eje.0.1460209","volume":"146","author":"JL Garcia","year":"2002","unstructured":"Garcia, J. L. et al. Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas. Eur. J. Endocrinol. 146 (2), 209\u2013213. https:\/\/doi.org\/10.1530\/eje.0.1460209 (2002).","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"55820_CR21","doi-asserted-by":"publisher","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","volume":"97","author":"PJ Newey","year":"2012","unstructured":"Newey, P. J. et al. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. J. Clin. Endocrinol. Metab. 97 (10), E1995\u20132005. https:\/\/doi.org\/10.1210\/jc.2012-2303 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"55820_CR22","doi-asserted-by":"publisher","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","volume":"97","author":"MK Cromer","year":"2012","unstructured":"Cromer, M. K. et al. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. J. Clin. Endocrinol. Metab. 97 (9), E1774\u20131781. https:\/\/doi.org\/10.1210\/jc.2012-1743 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"55820_CR23","doi-asserted-by":"publisher","first-page":"e46325","DOI":"10.1371\/journal.pone.0046325","volume":"7","author":"L Sulaiman","year":"2012","unstructured":"Sulaiman, L. et al. Genome-wide and locus specific alterations in CDC73\/HRPT2-mutated parathyroid tumors. PLoS One. 7 (9), e46325. https:\/\/doi.org\/10.1371\/journal.pone.0046325 (2012).","journal-title":"PLoS One"},{"issue":"4","key":"55820_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.surg.2015.06.022","volume":"158","author":"KL McCoy","year":"2015","unstructured":"McCoy, K. L. et al. The clinical importance of parathyroid atypia: is long-term surveillance necessary? Surgery 158 (4), 929\u2013935. https:\/\/doi.org\/10.1016\/j.surg.2015.06.022 (2015). discussion 935\u2009\u2013\u2009926.","journal-title":"Surgery"},{"issue":"Suppl 2","key":"55820_CR25","first-page":"2","volume":"23","author":"S Afonso","year":"2003","unstructured":"Afonso, S. et al. Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias. Nefrologia 23 (Suppl 2), 2\u20136 (2003).","journal-title":"Nefrologia"},{"issue":"6","key":"55820_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/s0039-6060(03)00422-7","volume":"134","author":"T Carling","year":"2003","unstructured":"Carling, T., Du, Y., Fang, W., Correa, P. & Huang, S. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas. Surgery 134 (6), 932\u2013939. https:\/\/doi.org\/10.1016\/s0039-6060(03)00422-7 (2003). discussion 939\u2013940.","journal-title":"Surgery"},{"issue":"1","key":"55820_CR27","first-page":"211","volume":"4","author":"J Chudek","year":"1998","unstructured":"Chudek, J., Ritz, E. & Kovacs, G. Genetic abnormalities in parathyroid nodules of uremic patients. Clin. Cancer Res. 4 (1), 211\u2013214 (1998).","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"55820_CR28","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1210\/jcem.82.7.4042","volume":"82","author":"A Falchetti","year":"1997","unstructured":"Falchetti, A. et al. Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 82 (7), 2278\u20132282. https:\/\/doi.org\/10.1210\/jcem.82.7.4042 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"55820_CR29","first-page":"331","volume":"163","author":"F Farnebo","year":"1997","unstructured":"Farnebo, F., Farnebo, L. O., Nordenstr\u00f6m, J. & Larsson, C. Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism. Eur. J. Surg. 163 (5), 331\u2013337 (1997).","journal-title":"Eur. J. Surg."},{"issue":"6","key":"55820_CR30","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/01.asn.0000018148.50109.c0","volume":"13","author":"Y Imanishi","year":"2002","unstructured":"Imanishi, Y. et al. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. J. Am. Soc. Nephrol. 13 (6), 1490\u20131498. https:\/\/doi.org\/10.1097\/01.asn.0000018148.50109.c0 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"55820_CR31","first-page":"1051","volume":"79","author":"N Koshiishi","year":"1999","unstructured":"Koshiishi, N. et al. Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland. Lab. Invest. 79 (9), 1051\u20131058 (1999).","journal-title":"Lab. Invest."},{"issue":"4","key":"55820_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/labinvest.3780261","volume":"81","author":"A Nagy","year":"2001","unstructured":"Nagy, A., Chudek, J. & Kovacs, G. Accumulation of Allelic Changes at Chromosomes 7p, 18q, and 2 in Parathyroid Lesions of Uremic Patients. Lab. Invest. 81 (4), 527\u2013533. https:\/\/doi.org\/10.1038\/labinvest.3780261 (2001).","journal-title":"Lab. Invest."},{"issue":"8","key":"55820_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/gcc.20565","volume":"47","author":"Y Yi","year":"2008","unstructured":"Yi, Y., Nowak, N. J., Pacchia, A. L. & Morrison, C. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays. Genes Chromosomes Cancer. 47 (8), 639\u2013648. https:\/\/doi.org\/10.1002\/gcc.20565 (2008).","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"55820_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/gcc.22194","volume":"53","author":"WE Corver","year":"2014","unstructured":"Corver, W. E. et al. Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations. Genes Chromosomes Cancer. 53 (10), 833\u2013844. https:\/\/doi.org\/10.1002\/gcc.22194 (2014).","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"55820_CR35","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1210\/jcem.87.8.8759","volume":"87","author":"E Szabo","year":"2002","unstructured":"Szabo, E., Carling, T., Hessman, O. & Rastad, J. Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalciuria and point mutation in calcium receptor. J. Clin. Endocrinol. Metab. 87 (8), 3961\u20133965. https:\/\/doi.org\/10.1210\/jcem.87.8.8759 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"55820_CR36","unstructured":"WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours. Lyon (France): International Agency for Research on Cancer;. (2022)."},{"issue":"3","key":"55820_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12022-015-9378-3","volume":"26","author":"P Howson","year":"2015","unstructured":"Howson, P. et al. Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation. Endocr. Pathol. 26 (3), 250\u2013254. https:\/\/doi.org\/10.1007\/s12022-015-9378-3 (2015).","journal-title":"Endocr. Pathol."},{"key":"55820_CR38","doi-asserted-by":"publisher","unstructured":"de Koster, E. J. et al. A clinically applicable molecular classification of oncocytic cell thyroid nodules. Endocr. Relat. Cancer. 30 (9). https:\/\/doi.org\/10.1530\/erc-23-0047 (2023).","DOI":"10.1530\/erc-23-0047"},{"issue":"9","key":"55820_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell, V. M. et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J. Med. Genet. 40 (9), 657\u2013663. https:\/\/doi.org\/10.1136\/jmg.40.9.657 (2003).","journal-title":"J. Med. Genet."},{"issue":"1","key":"55820_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/path.1489","volume":"202","author":"CJ Haven","year":"2004","unstructured":"Haven, C. J., van Puijenbroek, M., Karperien, M., Fleuren, G. J. & Morreau, H. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. J. Pathol. 202 (1), 86\u201394. https:\/\/doi.org\/10.1002\/path.1489 (2004).","journal-title":"J. Pathol."},{"issue":"11","key":"55820_CR41","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani, F. et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 89 (11), 5583\u20135591. https:\/\/doi.org\/10.1210\/jc.2004-0294 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"55820_CR42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/eje-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani, F. et al. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur. J. Endocrinol. 156 (5), 547\u2013554. https:\/\/doi.org\/10.1530\/eje-06-0720 (2007).","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"55820_CR43","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ijc.33166","volume":"147","author":"Y Hu","year":"2020","unstructured":"Hu, Y. et al. The genomic profile of parathyroid carcinoma based on whole-genome sequencing. Int. J. Cancer. 147 (9), 2446\u20132457. https:\/\/doi.org\/10.1002\/ijc.33166 (2020).","journal-title":"Int. J. Cancer"},{"key":"55820_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04193-4","author":"MM Jentus","year":"2025","unstructured":"Jentus, M. M. et al. Diagnosing the silent: the molecular landscape of non-functional parathyroid carcinoma. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-025-04193-4 (2025).","journal-title":"Virchows Arch."},{"issue":"5","key":"55820_CR45","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/s0002-9440(10)64796-7","volume":"157","author":"JV Bov\u00e9e","year":"2000","unstructured":"Bov\u00e9e, J. V. et al. Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am. J. Pathol. 157 (5), 1587\u20131595. https:\/\/doi.org\/10.1016\/s0002-9440(10)64796-7 (2000).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"55820_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41379-019-0330-9","volume":"33","author":"YP Hung","year":"2020","unstructured":"Hung, Y. P. et al. Molecular characterization of localized pleural mesothelioma. Mod. Pathol. 33 (2), 271\u2013280. https:\/\/doi.org\/10.1038\/s41379-019-0330-9 (2020).","journal-title":"Mod. Pathol."},{"issue":"1","key":"55820_CR47","doi-asserted-by":"publisher","first-page":"vdaa155","DOI":"10.1093\/noajnl\/vdaa155","volume":"2","author":"TG Baker","year":"2020","unstructured":"Baker, T. G. et al. Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma. Neurooncol Adv. 2 (1), vdaa155. https:\/\/doi.org\/10.1093\/noajnl\/vdaa155 (2020).","journal-title":"Neurooncol Adv."},{"key":"55820_CR48","doi-asserted-by":"publisher","unstructured":"Jentus, M. M. et al. Chromosomal Alteration Patterns in PitNETs: Massive Losses in Aggressive Tumors. Endocr Relat Cancer. (2024). https:\/\/doi.org\/10.1530\/erc-24-0070","DOI":"10.1530\/erc-24-0070"},{"issue":"1","key":"55820_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00401-024-02736-8","volume":"147","author":"AL Lin","year":"2024","unstructured":"Lin, A. L. et al. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors. Acta Neuropathol. 147 (1), 85. https:\/\/doi.org\/10.1007\/s00401-024-02736-8 (2024).","journal-title":"Acta Neuropathol."},{"issue":"2","key":"55820_CR50","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu, W. et al. Whole-Exome Sequencing Studies of Parathyroid Carcinomas Reveal Novel PRUNE2 Mutations, Distinctive Mutational Spectra Related to APOBEC-Catalyzed DNA Mutagenesis and Mutational Enrichment in Kinases Associated With Cell Migration and Invasion. J. Clin. Endocrinol. Metab. 100 (2), E360\u2013E364. https:\/\/doi.org\/10.1210\/jc.2014-3238 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"55820_CR51","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","volume":"24","author":"H Kang","year":"2019","unstructured":"Kang, H. et al. Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. Oncologist 24 (6), 791\u2013797. https:\/\/doi.org\/10.1634\/theoncologist.2018-0334 (2019).","journal-title":"Oncologist"},{"issue":"2","key":"55820_CR52","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/s0002-9440(10)64568-3","volume":"157","author":"S Kyt\u00f6l\u00e4","year":"2000","unstructured":"Kyt\u00f6l\u00e4, S. et al. Patterns of chromosomal imbalances in parathyroid carcinomas. Am. J. Pathol. 157 (2), 579\u2013586. https:\/\/doi.org\/10.1016\/s0002-9440(10)64568-3 (2000).","journal-title":"Am. J. Pathol."},{"issue":"4","key":"55820_CR53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cncy.22112","volume":"127","author":"YE Nikiforov","year":"2019","unstructured":"Nikiforov, Y. E. & Baloch, Z. W. Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology. Cancer Cytopathol. 127 (4), 225\u2013230. https:\/\/doi.org\/10.1002\/cncy.22112 (2019).","journal-title":"Cancer Cytopathol."},{"issue":"1","key":"55820_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/erc-17-0288","volume":"25","author":"WE Corver","year":"2018","unstructured":"Corver, W. E. et al. ROS-induced near-homozygous genomes in thyroid cancer. Endocr. Relat. Cancer. 25 (1), 83\u201397. https:\/\/doi.org\/10.1530\/erc-17-0288 (2018).","journal-title":"Endocr. Relat. Cancer"},{"issue":"10","key":"55820_CR55","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1210\/jcem.86.10.7894","volume":"86","author":"F Savagner","year":"2001","unstructured":"Savagner, F. et al. Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors. J. Clin. Endocrinol. Metab. 86 (10), 4920\u20134925. https:\/\/doi.org\/10.1210\/jcem.86.10.7894 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"55820_CR56","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1158\/2159-8290.Cd-14-0403","volume":"4","author":"SF Bakhoum","year":"2014","unstructured":"Bakhoum, S. F., Kabeche, L., Murnane, J. P., Zaki, B. I. & Compton, D. A. DNA-damage response during mitosis induces whole-chromosome missegregation. Cancer Discov. 4 (11), 1281\u20131289. https:\/\/doi.org\/10.1158\/2159-8290.Cd-14-0403 (2014).","journal-title":"Cancer Discov"},{"issue":"1","key":"55820_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/clinem\/dgae441","volume":"110","author":"E Pardi","year":"2024","unstructured":"Pardi, E. et al. Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid Tumorigenesis. J. Clin. Endocrinol. Metab. 110 (1), 48\u201358. https:\/\/doi.org\/10.1210\/clinem\/dgae441 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"55820_CR58","first-page":"338","volume":"128","author":"LS Bowlby","year":"1987","unstructured":"Bowlby, L. S., DeBault, L. E. & Abraham, S. R. Flow cytometric DNA analysis of parathyroid glands. Relationship between nuclear DNA and pathologic classifications. Am. J. Pathol. 128 (2), 338\u2013344 (1987).","journal-title":"Am. J. Pathol."},{"issue":"8","key":"55820_CR59","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/1097-0142(19900415)65:8<1789::aid-cncr2820650820>3.0.co;2-n","volume":"65","author":"T Obara","year":"1990","unstructured":"Obara, T. et al. Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma. Cancer 65 (8), 1789\u20131793. https:\/\/doi.org\/10.1002\/1097-0142(19900415)65:8%3C1789::aid-cncr2820650820%3E3.0.co;2-n (1990).","journal-title":"Cancer"},{"issue":"1","key":"55820_CR60","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1038\/s41598-023-34800-w","volume":"13","author":"A Bosman","year":"2023","unstructured":"Bosman, A. et al. Sexual dimorphisms in serum calcium and phosphate concentrations in the Rotterdam Study. Sci. Rep. 13 (1), 8310. https:\/\/doi.org\/10.1038\/s41598-023-34800-w (2023).","journal-title":"Sci. Rep."},{"key":"55820_CR61","doi-asserted-by":"publisher","unstructured":"Yavropoulou, M. P., Anastasilakis, A. D., Panagiotakou, A., Kassi, E. & Makras, P. Gender Predilection in Sporadic Parathyroid Adenomas. Int. J. Mol. Sci. 21 (8). https:\/\/doi.org\/10.3390\/ijms21082964 (2020).","DOI":"10.3390\/ijms21082964"},{"issue":"2","key":"55820_CR62","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","volume":"34","author":"I Ganly","year":"2018","unstructured":"Ganly, I. et al. Integrated Genomic Analysis of H\u00fcrthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. Cancer Cell. 34 (2), 256\u2013270e255. https:\/\/doi.org\/10.1016\/j.ccell.2018.07.002 (2018).","journal-title":"Cancer Cell."},{"key":"55820_CR63","first-page":"83","volume":"118","author":"K Inoue","year":"2017","unstructured":"Inoue, K. & Fry, E. A. Haploinsufficient tumor suppressor genes. Adv. Med. Biol. 118, 83\u2013122 (2017).","journal-title":"Adv. Med. Biol."},{"key":"55820_CR64","doi-asserted-by":"publisher","first-page":"1365474","DOI":"10.3389\/fonc.2024.1365474","volume":"14","author":"G Xie","year":"2024","unstructured":"Xie, G. et al. The role of imprinting genes\u2019 loss of imprints in cancers and their clinical implications. Front. Oncol. 14, 1365474. https:\/\/doi.org\/10.3389\/fonc.2024.1365474 (2024).","journal-title":"Front. Oncol."},{"key":"55820_CR65","doi-asserted-by":"publisher","unstructured":"Garrido, M. A. et al. Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer. Cancers (Basel). 13 (20). https:\/\/doi.org\/10.3390\/cancers13205046 (2021).","DOI":"10.3390\/cancers13205046"},{"issue":"1","key":"55820_CR66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.4756","volume":"240","author":"A Boot","year":"2016","unstructured":"Boot, A. et al. Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells. J. Pathol. 240 (1), 72\u201383. https:\/\/doi.org\/10.1002\/path.4756 (2016).","journal-title":"J. Pathol."},{"issue":"4","key":"55820_CR67","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Pont\u00e9n","year":"2008","unstructured":"Pont\u00e9n, F., Jirstr\u00f6m, K. & Uhlen, M. The Human Protein Atlas\u2014a tool for pathology. J. Pathol. 216 (4), 387\u2013393. https:\/\/doi.org\/10.1002\/path.2440 (2008).","journal-title":"J. Pathol."},{"issue":"7","key":"55820_CR68","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molmed.2010.05.001","volume":"16","author":"V Mieulet","year":"2010","unstructured":"Mieulet, V. & Lamb, R. F. Tuberous sclerosis complex: linking cancer to metabolism. Trends Mol. Med. 16 (7), 329\u2013335. https:\/\/doi.org\/10.1016\/j.molmed.2010.05.001 (2010).","journal-title":"Trends Mol. Med."},{"issue":"1","key":"55820_CR69","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s42003-023-04815-0","volume":"6","author":"J B\u00e1ez-Flores","year":"2023","unstructured":"B\u00e1ez-Flores, J., Rodr\u00edguez-Mart\u00edn, M. & Lacal, J. The therapeutic potential of neurofibromin signaling pathways and binding partners. Commun. Biol. 6 (1), 436. https:\/\/doi.org\/10.1038\/s42003-023-04815-0 (2023).","journal-title":"Commun. Biol."},{"issue":"5","key":"55820_CR70","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/eje.0.1460619","volume":"146","author":"T Dwight","year":"2002","unstructured":"Dwight, T. et al. Genetic analysis of lithium-associated parathyroid tumors. Eur. J. Endocrinol. 146 (5), 619\u2013627. https:\/\/doi.org\/10.1530\/eje.0.1460619 (2002).","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"55820_CR71","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1210\/clinem\/dgad136","volume":"108","author":"S Jha","year":"2023","unstructured":"Jha, S. et al. Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors. J. Clin. Endocrinol. Metab. 108 (10), 2686\u20132698. https:\/\/doi.org\/10.1210\/clinem\/dgad136 (2023).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55820-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:35:58Z","timestamp":1787873758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55820-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7834367\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27040"}}